The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China

被引:4
作者
Zhang, Xi-Ru [1 ,2 ]
Li, Zhi-Ju [1 ]
Fu, Qi [1 ]
Wang, Jin-Dong [1 ]
Huang, Qing-Mei [1 ]
Song, Wei-Qi [1 ]
Xu, Xiao-Yu [1 ]
Li, Zhi-Hao [1 ]
Mao, Chen [1 ,2 ]
机构
[1] Southern Med Univ, Sch Publ Hlth, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Zhujiang Hosp, Microbiome Med Ctr, Dept Lab Med, Guangzhou, Peoples R China
关键词
Coronavirus disease 2019; Vaccination; Coverage; Willingness; Related factor; COVID-19; VACCINE; OMICRON;
D O I
10.1186/s12889-023-15294-7
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundCOVID-19, which is caused by SARS-CoV-2, is a major global health threat. The dominant variant of SARS-CoV-2 has changed over time due to continuous evolution. We aimed to evaluate the coverage of SARS-CoV-2 vaccination among employees in China, explore their willingness to receive the SARS-CoV-2 variant vaccine and examine the potential factors influencing vaccination coverage and willingness.MethodsA cross-sectional epidemiological survey was conducted online from January 1, 2022, to January 30, 2022. The information collected in the survey included sociodemographic characteristics, lifestyle habits, vaccination coverage, willingness to be vaccinated against SARS-CoV-2 variants and the reasons for vaccination and willingness. Multivariable logistic regression models were used to assess the associations of potential factors with the rate of vaccination and the willingness to be vaccinated.ResultsAmong 62,395 eligible participants, the coverage of SARS-CoV-2 vaccination was 98.9% for at least one dose and 70.1% for a booster. The great majority of vaccinated individuals (94.4%) voluntarily received the vaccine. A total of 60,694 respondents (97.7%) were willing to be vaccinated against SARS-CoV-2 variants, mainly due to confidence in the effectiveness of vaccines (92.8%). A total of 1431 respondents were unwilling to be vaccinated, mainly because of concerns about the adverse effects of vaccines (77.6%). Longer education duration was associated with a higher rate of SARS-CoV-2 vaccination and willingness to be vaccinated. General or poor health status and having no history of influenza vaccination were associated with a lower rate of SARS-CoV-2 vaccination and willingness to be vaccinated. Additionally, we observed a significant positive association of abuse experience with the willingness to be vaccinated.ConclusionAlthough the rate of SARS-CoV-2 vaccination and the willingness to be vaccinated were relatively high in the study population, there were still some respondents with vaccine hesitancy. Relevant strategies based on significant related factors should be developed and implemented to encourage vaccination.
引用
收藏
页数:10
相关论文
共 25 条
  • [1] [Anonymous], RACE CLIN TRIALS OMI
  • [2] COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries
    Arce, Julio S. Solis
    Warren, Shana S.
    Meriggi, Niccolo F.
    Scacco, Alexandra
    McMurry, Nina
    Voors, Maarten
    Syunyaev, Georgiy
    Malik, Amyn Abdul
    Aboutajdine, Samya
    Adeojo, Opeyemi
    Anigo, Deborah
    Armand, Alex
    Asad, Saher
    Atyera, Martin
    Augsburg, Britta
    Awasthi, Manisha
    Ayesiga, Gloria Eden
    Bancalari, Antonella
    Nyqvist, Martina Bjorkman
    Borisova, Ekaterina
    Bosancianu, Constantin Manuel
    Cabra Garcia, Magarita Rosa
    Cheema, Ali
    Collins, Elliott
    Cuccaro, Filippo
    Farooqi, Ahsan Zia
    Fatima, Tatheer
    Fracchia, Mattia
    Galindo Soria, Mery Len
    Guariso, Andrea
    Hasanain, Ali
    Jaramillo, Sofia
    Kallon, Sellu
    Kamwesigye, Anthony
    Kharel, Arjun
    Kreps, Sarah
    Levine, Madison
    Littman, Rebecca
    Malik, Mohammad
    Manirabaruta, Gisele
    Mfura, Jean Leodomir Habarimana
    Momoh, Fatoma
    Mucauque, Alberto
    Mussa, Imamo
    Nsabimana, Jean Aime
    Obara, Isaac
    Juliana Otalora, Maria
    Ouedraogo, Bechir Wendemi
    Pare, Touba Bakary
    Platas, Melina R.
    [J]. NATURE MEDICINE, 2021, 27 (08) : 1385 - +
  • [3] Factors Associated With Parental Acceptance of COVID-19 Vaccination: A Multicenter Pediatric Emergency Department Cross-Sectional Analysis
    Baumann, Brigitte M.
    Rodriguez, Robert M.
    DeLaroche, Amy M.
    Rayburn, David
    Eucker, Stephanie A.
    Nadeau, Nicole L.
    Drago, Lisa A.
    Cullen, Danielle
    Meskill, Sarah Dennis
    Bialeck, Suzanne
    Gillman, Michael
    [J]. ANNALS OF EMERGENCY MEDICINE, 2022, 80 (02) : 130 - 142
  • [4] Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
    Bernal, Jamie Lopez
    Andrews, Nick
    Gower, Charlotte
    Gallagher, Eileen
    Simmons, Ruth
    Thelwall, Simon
    Stowe, Julia
    Tessier, Elise
    Groves, Natalie
    Dabrera, Gavin
    Myers, Richard
    Campbell, Colin N. J.
    Amirthalingam, Gayatri
    Edmunds, Matt
    Zambon, Maria
    Brown, Kevin E.
    Hopkins, Susan
    Chand, Meera
    Ramsay, Mary
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07) : 585 - 594
  • [5] OMICRON LIKELY TO WEAKEN COVID VACCINE PROTECTION
    Callaway, Ewen
    [J]. NATURE, 2021, 600 (7889) : 367 - 368
  • [6] HEAVILY MUTATED OMICRON VARIANT PUTS SCIENTISTS ON ALERT
    Callaway, Ewen
    [J]. NATURE, 2021, 600 (7887) : 21 - 21
  • [7] Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
    Cao, Yunlong
    Wang, Jing
    Jian, Fanchong
    Xiao, Tianhe
    Song, Weiliang
    Yisimayi, Ayijiang
    Huang, Weijin
    Li, Qianqian
    Wang, Peng
    An, Ran
    Wang, Yao
    Niu, Xiao
    Yang, Sijie
    Liang, Hui
    Sun, Haiyan
    Li, Tao
    Yu, Yuanling
    Cui, Qianqian
    Liu, Shuo
    Yang, Xiaodong
    Du, Shuo
    Zhang, Zhiying
    Hao, Xiaohua
    Shao, Fei
    Jin, Ronghua
    Wang, Xiangxi
    Xiao, Junyu
    Wang, Youchun
    Xie, Xiaoliang Sunney
    [J]. NATURE, 2022, 602 (7898) : 657 - +
  • [8] Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
    Dhama, Kuldeep
    Nainu, Firzan
    Frediansyah, Andri
    Yatoo, Mohd Iqbal
    Mohapatra, Ranjan K.
    Chakraborty, Sandip
    Zhou, Hao
    Islam, Md. Rabiul
    Mamada, Sukamto S.
    Kusuma, Hendrix Indra
    Rabaan, Ali A.
    Alhumaid, Saad
    Al Mutair, Abbas
    Iqhrammullah, Muhammad
    Al-Tawfiq, Jaffar A.
    Al Mohaini, Mohammed
    Alsalman, Abdulkhaliq J.
    Tuli, Hardeep Singh
    Chakraborty, Chiranjib
    Harapan, Harapan
    [J]. JOURNAL OF INFECTION AND PUBLIC HEALTH, 2023, 16 (01) : 4 - 14
  • [9] Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants
    Edara, Venkata-Viswanadh
    Pinsky, Benjamin A.
    Suthar, Mehul S.
    Lai, Lilin
    Davis-Gardner, Meredith E.
    Floyd, Katharine
    Flowers, Maria W.
    Wrammert, Jens
    Hussaini, Laila
    Ciric, Caroline Rose
    Bechnak, Sarah
    Stephens, Kathy
    Graham, Barney S.
    Bayat Mokhtari, Elham
    Mudvari, Prakriti
    Boritz, Eli
    Creanga, Adrian
    Pegu, Amarendra
    Derrien-Colemyn, Alexandrine
    Henry, Amy R.
    Gagne, Matthew
    Douek, Daniel C.
    Sahoo, Malaya K.
    Sibai, Mamdouh
    Solis, Daniel
    Webby, Richard J.
    Jeevan, Trushar
    Fabrizio, Thomas P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07) : 664 - 666
  • [10] Perceptions of the safety of vaccines and vaccine associated knowledge levels in Europe: A 2019 cross-sectional study in 28 countries
    Foster, Philippa J. I.
    Laverty, Anthony A.
    Filippidis, Filippos T.
    [J]. PREVENTIVE MEDICINE, 2022, 159